Lilly declares fourth-quarter 2025 dividend

Dividend Announcement - Eli Lilly and Company has declared a fourth-quarter dividend of $1.50 per share on outstanding common stock, payable on December 10, 2025, to shareholders of record at the close of business on November 14, 2025 [1] Company Overview - Eli Lilly is a pharmaceutical company focused on turning scientific discoveries into healing solutions, with nearly 150 years of experience in pioneering life-changing medicines that help tens of millions globally [2] - The company is advancing new discoveries in various health challenges, including diabetes care, obesity treatment, Alzheimer's disease, immune system disorders, and difficult-to-treat cancers [2] Recent Developments - Eli Lilly has partnered with Shaquille O'Neal to raise awareness for moderate-to-severe obstructive sleep apnea [3] - New data indicates that Omvoh (mirikizumab-mrkz) has shown early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis [4]